CONCLUSION: IL-1 may be under the control of estrogen in vivo and may be attenuated by antiestrogen therapy and diet modifications. The increased IL-1Î² in breast cancers of women strongly suggests IL-1 as a potential therapeutic target in breast cancer treatment and prevention. 